Elizabeth Hellstrom

Paarl, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years).

Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years).

Journal: BMC infectious diseases

Published: May 04, 2026

Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.

Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.

Journal: The Journal of infectious diseases

Published: April 30, 2026

BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.

BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.

Journal: The New England journal of medicine

Published: May 07, 2025

A novel and safe SmartCap® SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans.

A novel and safe SmartCap® SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans.

Journal: Frontiers in immunology

Published: February 04, 2025

Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.

Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.

Journal: Journal of the International AIDS Society

Published: April 18, 2024

Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.

Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.

Journal: The lancet. HIV

Published: June 29, 2023

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Journal: The New England journal of medicine

Published: October 30, 2019

Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.

Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: December 22, 2018

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Journal: The New England journal of medicine

Published: October 04, 2018

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial.

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial.

Journal: PloS one

Published: January 24, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026